Cargando…

Mismatch repair gene mutations and cancer risks: an update

Detalles Bibliográficos
Autores principales:	Win, AK, Hopper, JL, Jenkins, MA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326693/ http://dx.doi.org/10.1186/1897-4287-10-S2-A22

Ejemplares similares

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
por: Dowty, JG, et al.
Publicado: (2012)

Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome
por: Parry, S, et al.
Publicado: (2012)

The relationship between the BRAF p.V600E mutation and a family history of CRC in the early-onset CRC cases from the Australasian Colon Cancer Family Study
por: Buchanan, DD, et al.
Publicado: (2012)

Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants
por: Thompson, B, et al.
Publicado: (2012)

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance
por: Parsons, M, et al.
Publicado: (2012)

A study of cancer risks in relatives of patients with serrated polyposis
por: Win, AK, et al.
Publicado: (2012)

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers – the advantage of more extensive surgery
por: Parry, Susan, et al.
Publicado: (2011)

The InSiGHT approach to classification of mismatch repair gene variants
por: Plazzer, JP
Publicado: (2012)

Audit of routine immunohistochemistry testing for mismatch repair proteins at diagnosis of colorectal cancer under the age of 50
por: Lipton, L, et al.
Publicado: (2012)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Hereditary Aspects of Colorectal Cancer: Mismatch Repair Genes Drive Lynch Syndrome
por: Hampel, Heather, et al.
Publicado: (2018)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing
por: Teo, ZL, et al.
Publicado: (2012)

Mutations and polymorphisms of genes moderate increase in gastric cancer risk
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes
por: Win, A K, et al.
Publicado: (2011)

DNA mismatch repair gene mutations in human cancer.
por: Peltomäki, P
Publicado: (1997)

The mutation P392L of the sequestosome 1 gene in Paget's disease of bone is frequent in the French population
por: Michou, L, et al.
Publicado: (2003)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Molecular mutation characteristics of mismatch and homologous recombination repair genes in gastrointestinal cancer
por: Liu, Xingcun, et al.
Publicado: (2019)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012)

Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
por: Bugoye, Fidelis Charles, et al.
Publicado: (2023)

DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands
por: Walker, Romy, et al.
Publicado: (2023)

Nitric oxide (NO) metabolite levels are not increased during hypotensive periods in human sepsis
por: Jenkins, DH, et al.
Publicado: (1998)

‘Next-generation’ genome wide association studies
por: Hopper, J, et al.
Publicado: (2012)

Technology update
por: Young, KC
Publicado: (2002)

Guidelines update
por: Demirkiran, Oktay
Publicado: (2015)

Validation of Prediction Models for Mismatch Repair Gene Mutations in Koreans
por: Lee, Soo Young, et al.
Publicado: (2016)

DNA mismatch repair preferentially protects genes from mutation
por: Belfield, Eric J., et al.
Publicado: (2018)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Constitutional mutations of cancer susceptibility genes in the health workers professionally exposed to cytostatic drugs
por: Janiszewska, H, et al.
Publicado: (2011)

Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes.
por: Hechtman, Jaclyn F., et al.
Publicado: (2019)

Scapholunate tears: an update
por: Mathoulin, Christophe
Publicado: (2015)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
por: Sawyer, S, et al.
Publicado: (2012)

The case of the youngest infant with hepatoblastoma with APC gene mutation
por: Krawczuk-Rybak, Maryna, et al.
Publicado: (2012)

Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
por: Moers, C, et al.
Publicado: (2001)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_h0fjf1uf9goq8ntsvfl6fp1lak